Histological recovery of a rejecting intestinal graft after treatment with mesenchymal stem cells: continuing evidence of similarities with inflammatory bowel disease

Br J Surg. 2022 Feb 1;109(2):e21-e23. doi: 10.1093/bjs/znab415.

Authors

Amy L Lightner¹, Masato Fujiki², Mohammed Osman², Giuseppe D'Amico³, Anita Barnoski², Clifton G Fulmer⁴, Anil Vaidya²

Affiliations

¹ Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA.
² Department of Abdominal Transplantation, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA.
³ Center for Gut Rehabilitation and Transplantation, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA.
⁴ Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Ohio, USA.

PMID: 34931658
DOI: 10.1093/bjs/znab415

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Anti-Inflammatory Agents / therapeutic use*
Biological Products / therapeutic use*
Colon / transplantation*
Graft Rejection / drug therapy*
Humans
Intestine, Small / transplantation*
Male
Mesenchymal Stem Cells / cytology*
Short Bowel Syndrome / surgery*
Transplantation, Homologous

Substances

Anti-Inflammatory Agents
Biological Products
remestemcel-l